BRPI0822061A2 - Moduladores do receptor canabinoide - Google Patents
Moduladores do receptor canabinoideInfo
- Publication number
- BRPI0822061A2 BRPI0822061A2 BRPI0822061-1A BRPI0822061A BRPI0822061A2 BR PI0822061 A2 BRPI0822061 A2 BR PI0822061A2 BR PI0822061 A BRPI0822061 A BR PI0822061A BR PI0822061 A2 BRPI0822061 A2 BR PI0822061A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor modulators
- cannabinoid receptor
- cannabinoid
- modulators
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0724096A GB0724096D0 (en) | 2007-12-10 | 2007-12-10 | Cannabinoid receptor modulators |
| GB0813350A GB0813350D0 (en) | 2008-07-21 | 2008-07-21 | Cannabinoid receptor modulators |
| PCT/GB2008/004051 WO2009074782A1 (en) | 2007-12-10 | 2008-12-08 | Cannabinoid receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0822061A2 true BRPI0822061A2 (pt) | 2015-06-23 |
Family
ID=40344724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0822061-1A BRPI0822061A2 (pt) | 2007-12-10 | 2008-12-08 | Moduladores do receptor canabinoide |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8173680B2 (pt) |
| EP (1) | EP2231615A1 (pt) |
| JP (1) | JP2011506410A (pt) |
| KR (1) | KR20100091255A (pt) |
| CN (1) | CN101896465A (pt) |
| AU (1) | AU2008334489A1 (pt) |
| BR (1) | BRPI0822061A2 (pt) |
| CA (1) | CA2708706A1 (pt) |
| EA (1) | EA018900B1 (pt) |
| IL (1) | IL205980A0 (pt) |
| MX (1) | MX2010006109A (pt) |
| NZ (1) | NZ585704A (pt) |
| WO (1) | WO2009074782A1 (pt) |
| ZA (1) | ZA201004828B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079967A1 (es) * | 2010-01-26 | 2012-02-29 | Sanofi Aventis | Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos |
| US8962845B2 (en) * | 2011-09-30 | 2015-02-24 | National Health Research Institutes | Pyrazole compounds |
| US9505728B2 (en) | 2012-03-09 | 2016-11-29 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| JP6272626B2 (ja) | 2012-11-13 | 2018-01-31 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | カンナビノイド受容体媒介性化合物 |
| US11155521B2 (en) * | 2012-11-13 | 2021-10-26 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cannabinoid receptor mediating compounds |
| MX2015007433A (es) | 2012-12-20 | 2015-12-07 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos. |
| WO2015035059A1 (en) | 2013-09-06 | 2015-03-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| EP3140288B1 (en) | 2014-05-09 | 2023-01-25 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Pyrazole derivatives and their use as cannabinoid receptor mediators |
| US11091447B2 (en) | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2856683A1 (fr) * | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
| MX2007004889A (es) * | 2004-10-25 | 2007-09-11 | Solvay Pharm Gmbh | Composiciones farmaceuticas que comprenden antagonistas del receptor cannabinoide cb1 y activadores de canales de potasio para el tratamiento de la diabetes mellitus tipo i, la obesidad y trastornos relacionados. |
| EP1831177A1 (en) * | 2004-12-23 | 2007-09-12 | AstraZeneca AB | Therapeutic agents |
| US20080200527A1 (en) * | 2005-06-17 | 2008-08-21 | Carex Sa | Cannabinoid Receptor Modulators |
| JP5069894B2 (ja) * | 2005-10-21 | 2012-11-07 | 田辺三菱製薬株式会社 | ピラゾール化合物 |
| ATE538650T1 (de) * | 2006-03-10 | 2012-01-15 | Jenrin Discovery | Cannabinoid-rezeptor-antagonisten / inverse agonisten zur behandlung von übergewicht |
| WO2007138050A1 (en) * | 2006-05-31 | 2007-12-06 | Solvay Pharmaceuticals B.V. | Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists |
| GB0622569D0 (en) * | 2006-11-11 | 2006-12-20 | 7Tm Pharma As | Cannabinoid receptor modulators |
| US8124634B2 (en) * | 2006-12-18 | 2012-02-28 | 7Tm Pharma A/S | CB1 receptor modulators |
-
2008
- 2008-12-08 WO PCT/GB2008/004051 patent/WO2009074782A1/en active Application Filing
- 2008-12-08 CA CA2708706A patent/CA2708706A1/en not_active Abandoned
- 2008-12-08 AU AU2008334489A patent/AU2008334489A1/en not_active Abandoned
- 2008-12-08 NZ NZ585704A patent/NZ585704A/xx not_active IP Right Cessation
- 2008-12-08 US US12/745,708 patent/US8173680B2/en not_active Expired - Fee Related
- 2008-12-08 EP EP08860004A patent/EP2231615A1/en not_active Withdrawn
- 2008-12-08 BR BRPI0822061-1A patent/BRPI0822061A2/pt not_active IP Right Cessation
- 2008-12-08 KR KR1020107015316A patent/KR20100091255A/ko not_active Application Discontinuation
- 2008-12-08 MX MX2010006109A patent/MX2010006109A/es not_active Application Discontinuation
- 2008-12-08 EA EA201000971A patent/EA018900B1/ru not_active IP Right Cessation
- 2008-12-08 CN CN200880120649XA patent/CN101896465A/zh active Pending
- 2008-12-08 JP JP2010537504A patent/JP2011506410A/ja active Pending
-
2010
- 2010-05-26 IL IL205980A patent/IL205980A0/en unknown
- 2010-07-08 ZA ZA2010/04828A patent/ZA201004828B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009074782A1 (en) | 2009-06-18 |
| EP2231615A1 (en) | 2010-09-29 |
| ZA201004828B (en) | 2011-03-30 |
| CN101896465A (zh) | 2010-11-24 |
| EA018900B1 (ru) | 2013-11-29 |
| AU2008334489A1 (en) | 2009-06-18 |
| CA2708706A1 (en) | 2009-06-18 |
| NZ585704A (en) | 2012-08-31 |
| US20100292273A1 (en) | 2010-11-18 |
| US8173680B2 (en) | 2012-05-08 |
| IL205980A0 (en) | 2010-11-30 |
| EA201000971A1 (ru) | 2011-02-28 |
| KR20100091255A (ko) | 2010-08-18 |
| MX2010006109A (es) | 2010-09-10 |
| JP2011506410A (ja) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259082A1 (zh) | 大麻素受體調節劑 | |
| ATE537157T1 (de) | Substituierte phenoxy-n-alkylierte thiazoledindione als östrogenassoziierte rezeptor-alpha-modulatoren | |
| BRPI0813653A2 (pt) | Compostos de imidazotiazol moduladores de sirtuína | |
| BRPI0813651A2 (pt) | Compostos de tiazolopiridina moduladores de sirtuína | |
| BRPI0923305A2 (pt) | moduladores de receptores toll-like | |
| DK2262808T3 (da) | Chemokinreceptormodulatorer | |
| DK2297100T3 (da) | Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer | |
| DE602007006531D1 (de) | Pyrazin-2-carboxamid-derivate als cb2-rezeptormodulatoren | |
| BRPI0810815A2 (pt) | Dispositivo de fixação | |
| BRPI0907844A2 (pt) | moduladores seletivos do receptor de andrógeno | |
| DE502007006120D1 (de) | Hochverfügbares Kommunikationssystem | |
| BRPI0822061A2 (pt) | Moduladores do receptor canabinoide | |
| GB0625196D0 (en) | Modulators of cannabinoid receptor | |
| BRPI0813230A2 (pt) | Moduladores de calicreína 7 | |
| GB0701992D0 (en) | Grehlin Receptor Modulators | |
| BRPI0816154A2 (pt) | Moduladores canabinóides de 5-vinilfenil-1-fenil-pirazol substituídos | |
| DK2215803T3 (da) | Netværksadgang-autorisering | |
| DK2147106T3 (da) | Expressionssystem | |
| ATE475602T1 (de) | AUSGIEßER | |
| IL200957A0 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| GB0622569D0 (en) | Cannabinoid receptor modulators | |
| DE602006005138D1 (de) | Nichtsteroide glucocorticoid-rezeptormodulatoren | |
| BRPI0818773A2 (pt) | Moduladores de gama-secretase ligados a carbono | |
| ATE487723T1 (de) | Substituierte furoä2,3-büpyridinderivate als cannabinoid-1-rezeptormodulatoren | |
| DE602007008589D1 (de) | Pyridooxazepin-progesteronrezeptor-modulatoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |